The current program for prevention of mother-to-child HIV transmission in Thailand recommends a 2-drugs regimen for HIV-infected pregnant women with a CD4 count >200 cells/mm3. This study assesses the value for money of 3 antiretroviral drugs compared with zidovudine (AZT)+single-dose nevirapine (sd-NVP). A decision tree was constructed to predict costs and outcomes using the governmental perspective for assessing cost-effectiveness of 3-drug regimens: (1) AZT, lamivudine, and efavirenz and (2) AZT, 3TC, and lopinavir/ritonavir, in comparison with the current protocol, AZT+sd-NVP. The 3-drug antiretroviral regimens yield lower costs and better health outcomes compared with AZT+sd-NVP. Although these 3-drug regimens offer higher program costs and health care costs for premature birth, they save money significantly in regard to pediatric HIV treatment and treatment costs for drug resistance in mothers. The 3-drug regimens are cost-saving interventions. The findings from this study were used to support a policy change in the national recommendation.
National AIDS Prevention and Alleviation Committee. UNGRASS Country Progress Report, Thailand, Reporting Period January 2006-December 2007. Nonthaburi, Thailand: Office of Technical Development to Support HIV/AIDS Responses,Department of Disease Control, Ministry of Public Health; 2008.
2.
McIntyreJLallemantM.The prevention of mother-to-child transmission of HIV: are we translating scientific success into programmatic failure?Curr Opin HIV AIDS. 2008;3:139-145.
3.
KanshanaSSimondsRJ.National program for preventing mother-child HIV transmission in Thailand: successful implementation and lessons learned. AIDS. 2002;16:953-959.
4.
TeerawattananonYVosTTangcharoensathienVMugfordM.Cost-effectiveness of models for prevention of vertical HIV transmission: voluntary counseling and testing and choices of drug regimen. Cost Eff Resour Alloc. 2005;3:7.
5.
NaiwatanakulTPunsuwanNKullerkN. Reduction in HIV transmission risk following recommendations for CD4 testing to guide selection of prevention of mother-to-child (PMTCT) regimens, Thailand, 2006-2007. Paper presented at: 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 19-22, 2009; Cape Town, South Africa.
6.
ChaikledkaewUTeerawatananonYKhongpittayachaiSSuksomboonN.Thai Health Technology Assessment Guidelines [in Thai]. Nonthaburi, Thailand: Working Group Development of Thai National Health Technology Assessment Guidelines; 2009.
7.
PunsuwanN.Results from 14 provinces pilot surveillance define to determine the impact of maternal perinatal prevention program Thailand. WESR. 2009;40:293-296.
8.
Department of Health, Bureau of Epidemiology, Thailand MOPH–US CDC Collaboration. Evaluation of Thailand’s National PMTCT Program. Nonthaburi, Thailand: Department of Health; 2008.
9.
ShafferNChuachoowongRMockPA. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet. 1999;353:773-780.
10.
CoutsoudisADabisFFawziW. Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis. 2004;189:2154-2166.
11.
GoetghebuerTHaeltermanEMarvilletI. Vertical transmission of HIV in Belgium: a 1986-2002 retrospective analysis. Eur J Pediatr. 2009;168:79-85.
12.
TownsendCLCortina-BorjaMPeckhamCSde RuiterALyallHTookeyPA.Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS. 2008;22:973-981.
13.
WarszawskiJTubianaRLe ChenadecJ. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS. 2008;22:289-299.
14.
CooperERCharuratMMofensonL. Combination antiretroviral strategies for the treatment of pregnant HIV-1-Infected woman and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2001;29:484-494.
15.
McConnellMSStringerJSKiarieJ. Effectiveness of non-nucleoside reverse transcriptase inhibitor-containing antiretroviral therapy in women previously exposed to a single dose of nevirapine: a multi-country cohort study. Paper presented at: 2008 HIV/AIDS Implementers’ Meeting, B71089 Presentation; June 3-7, 2008; Kampala, Uganda.
16.
PalmerSBoltzVMaldarelliF. Short-course combivir (CBV) single dose nevirapine reduces but does not eliminate the selection of nevirapine-resistance HIV-1: improved detection by allele-specific PCR. Paper presented at: 14th International HIV Drug Resistance Workshop; June 7-11, 2005; Quebec City, Canada.
17.
PunsuwanNNaiwatanakulTKullerkN. Uptake of national recommendations for provision of a 7-day postpartum regimen for prevention of mother-to-child HIV transmission (PMTCT), Thailand, 2006-2007. Paper presented at: 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 19-22, 2009; Cape Town, South Africa.
18.
KourtisAPSchmidCHJamiesonDJLauJ.Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS. 2007;21:607-615.
19.
LeelukkanaveeraYSithisarankulPHiransuthikulNTeerawatananonY.An Economic Evaluation of Routine Offer HIV Counseling and Testing of Out-Patients at Community Hospitals in Thailand [PhD dissertation]. Bangkok, Thailand: Faculty of Medicine, Chulalongkorn University; 2009.
20.
The Thai Working Group on Burden of Disease and Injuries. Burden of Disease and Injuries in Thailand: Prority Setting for Policy. Nonthaburi, Thailand: International Health Policy Program; 2002.
21.
MaleewongUKulsomboonVTeerawattananonY.The cost-effectiveness analysis of initiating HIV/AIDS treatment with efavirenz-based regimens compared with nevirapine-based regimens in Thailand. J Med Assoc Thai. 2008;91(suppl 2):S126-S138.
22.
LeelahavarongPTeerawattananonYWerayingyongP. Economic Evaluation of Prime-Boost HIV Vaccine (ALVAC-HIV and AIDSVAX B/E) for the Thai Population. Nonthaburi, Thailand: Health Intervention and Technology Assessment Program; 2010.
23.
NeramitpitagkulPLertpitakpongCYothasamutJThavorncharoensapMChaikledkaewUTeerawattananonY.Economic impact on health-care costs related to major diseases including HIV/AIDS due to alcohol drinking among Thai populations. Value Health. 2009;12(suppl 3):S97-S100.
24.
LallemantMJourdainGLe CoeurS. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med. 2004;351:217-228.
25.
LehmanDAChungMHMabukaJM. Lower risk of resistance after short-course HAART compared with zidovudine/single-dose nevirapine used for prevention of HIV-1 mother-to-child transmission. J Acquir Immune Defic Syndr. 2009;51:522-529.
26.
World Health Organization. Rapid Advice: Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. Geneva, Switzerland: World Health Organization; 2009.
27.
RobberstadBEvjen-OlsenB.Preventing mother to child transmission of HIV with highly active antiretroviral treatment in Tanzania: a prospective cost-effectiveness study. J Acquir Immune Defic Syndr. 2010;55:397-403.
28.
ShahMJohnsBAbimikuAWalkerDG.Cost-effectiveness of new WHO recommendations for prevention of mother-to-child transmission of HIV in a resource-limited setting. AIDS. 2011;25:1093-1102.
29.
CiaranelloALPerezFEngelsmannB. Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe. Clin Infect Dis. 2013;56:430-446.
30.
YamabhaiIMoharaAKrichananWChaisiriKTantivessSTeerawattananonY.Assessing the Implications of Thailand’s Government Use Licenses, Issued in 2006-2008. Nonthaburi, Thailand: Health Intervention and Technology Assessment Program; 2009.
31.
Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recomendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions reduce perinatal HIV transmission in the United States. http://aidsinfo.nih.gov/ContentFiles/PerinatalGL.pdf. Accessed January 5, 2009.
32.
Department of Health. Thai National Guidelines for the Prevention of Mother-to-Child Transmission of HIV. Nonthaburi, Thailand: Department of Health, Ministry of Public Health; 2012.
